Comparing the Safety and Efficacy of Apixaban and Rivaroxaban

NCT06953726 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

10000

Enrollment

FED

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Apixaban
DRUG: Rivaroxaban

Sponsor

VA Office of Research and Development

Collaborators

[object Object]